FDA authorizes Vitestro's Aletta robot for autonomous blood draws

Aletta handles the needle stick, tube changes and bandaging, while one trained phlebotomist can supervise three machines.

By · Published

Primary source: Forbes

Why it matters

Vitestro has secured the first U.S. authorization for a standalone robotic blood-draw system, creating a regulatory path for automating routine phlebotomy. Commercial adoption will turn on supervision costs, reliability and workflow integration.

FDA authorized Vitestro's robot to draw blood without hands-on help — Aletta handles the needle stick, tube changes and bandaging, while one trained phlebotomist can supervise three machines.

Toon Overbeeke and Brian Joseph spent nine years turning two difficult family blood-draw experiences into Aletta, and on August 19th, 2026, the FDA authorized their robot to perform the procedure without hands-on operator intervention.…

Reader comments

Conversation for this story loads after sign-in.